Columnist Oluwatosin Adesoye once feared how sickle cell complications would affect her future, but they ended up opening ...

CSL is investigating two potential new treatments for sickle cell disease: An injected monoclonal antibody designed to ...

The U.S. Food and Drug Administration is speeding up its review of an oral medicine for sickle cell disease that may fill a ...

Casgevy is now approved in the U.S. for children with sickle cell as young as 2, becoming the first gene-editing therapy for ...

Mutations in the HBB gene cause SCD by leading to the production of a faulty version of hemoglobin (the protein that helps red blood cells transport oxygen), which tends to clump inside red blood ...

When good specialists from a healthcare team move on, it can disrupt a patient's world, writes columnist Mary Shaniqua. But ...

A new, interactive application touted as the first of its kind can help people with sickle cell disease (SCD) learn about and communicate with their care team about their pain attacks. People with ...

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google The quiet, creeping isolation that comes with living with sickle ...

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit That will include data from the study’s third-highest dosing group, with data from the highest ...

A sickle cell crisis isn’t a polite guest, and it often arrives unannounced. Over the years, I’ve learned that my crises either come on suddenly or build gradually, with subtle clues or a red alert.

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google The use of pharmaceutical disease-modifying therapies (pDMTs) has ...

Researchers have developed a modelling system of tiny blood vessels to track inflammation-driven blood clot formation that can cause complications in sickle cell disease (SCD) and other conditions.